ECM
CNMD icon

Evergreen Capital Management’s CONMED CNMD Stock Holding History

Evergreen Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Buy
+8,416
New +$303K ﹤0.01% 1267
2024
Q1 		– Sell
-2,317
Closed -$254K – 882
2023
Q4 		$254K Buy
2,317
+133
+6% +$13.8K 0.01% 669
2023
Q3 		$221K Sell
2,184
-318
-13% -$36.5K 0.01% 672
2023
Q2 		$340K Buy
2,502
+530
+27% +$64.7K 0.01% 510
2023
Q1 		$205K Buy
+1,972
New +$191K 0.01% 652

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Evergreen Capital Management's CNMD Position: Q2 2026 in Review

Evergreen Capital Management opened a new position in CONMED (CNMD) in Q2 2026: 8,416 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #1267 among its holdings. This is a return to the name: Evergreen Capital Management previously reported a position in CNMD as recently as Q4 2023.

Evergreen Capital Management first reported a position in CNMD in Q1 2023 and has held it in 5 quarters since. The position peaked at $340K in Q2 2023. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Evergreen Capital Management held 8,416 shares of CONMED worth $275K as of Q2 2026.
  • CONMED was a new Evergreen Capital Management position in Q2 2026.
  • CONMED made up ﹤0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1267 holding.
  • Evergreen Capital Management first reported a position in CONMED in Q1 2023 and has held it in 5 quarters since.
  • Evergreen Capital Management's CONMED position peaked at $340K in Q2 2023.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.